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SUMMARY	
Healthcare systems around the world continue to see their expenditures increase, 
measured as a percentage of gross domestic product. Within health economics, the 
need for models that can predict healthcare costs is of substantial importance, as 
decisions to introduce as well as to decommission healthcare services are based on 
these. This dissertation is an attempt to highlight the importance of epidemiological 
factors for health economic research on chronic diseases. Hence, the research 
question of interest is: how do individual epidemiological and behavioural factors 
impact the healthcare utilisation of patients with a chronic disease, e.g. osteoporosis? 
This dissertation proposes a framework for predicting healthcare utilisation which 
includes four steps: familiarisation with the study population, determining the 
appropriate resource use, determining which predictors are important to consider, and 
lastly choosing the most appropriate statistical model. This framework was developed 
as a result of five quantitative studies, of which four were based on patient specific 
data from registers, and one on cost of illness theory. The framework was applied for 
predicting the cost for all fractures patients in one year following the fracture, i.e. the 
fifth study included in this dissertation. This study showed that it is not only important 
to understand the population of interest, as this eases the subsequent identification of 
potential predictors, but also the healthcare system through which these patients are 
treated, as different resources were affected differently by the clinical and 
behavioural predictors included.  
In conclusion, the results from this dissertation highlight the importance being 
familiar with the population of interest, identifying the relevant resources, including 
both epidemiological and behavioural predictors, when analysing outcomes from 
both an epidemiological and health economic perspective, and choosing the right 
statistical model to analyse all this with. Both health and social scientists interested 
in researching utilisation of healthcare should consider these four steps. 
 	
RESUME	
Mængden af penge som bruges på sundhedsvæsner rundt om i verden er enorm, og 
på trods af adskillelige finanskriser, bliver den relative andel af vores forbrug på 
sundhed ved med at sige. Inden for sundhedsøkonomisk forskning er behovet for 
modeller som kan prædiktere sundhedsomkostninger stigende, fordi udbydere af 
sundhedsydelser i mange lande baserer deres beslutninger om at tilbyde eller afskaffe 
disse ydelser på sådanne modeller. Denne afhandling er en forsøg på at belyse 
vigtigheden af epidemiologisk forskning i forhold til sundhedsøkonomisk forskning 
af kroniske sygdomme. Forskningsspørgsmålet for denne afhandling er derfor 
hvordan individers epidemiologiske og adfærdsbestemte karakteristika har ind-
flydelse på forbrug af sundhedsydelser for patienter med en kronisk sygdom, som 
eksempelvis knogleskørhed. 
I denne afhandling præsenteres en model for hvordan forbrug af sundhedsydelser kan 
prædikteres. Denne model er baseret på erfaringer fra fem tilhørende kvantitative 
studier, hvoraf fire er baseret på individ data fra danske registre og et studie er baseret 
på cost-of-illness teori. I denne afhandling blev modellen testen på en population af 
danskere som pådrog sig et knoglebrud. Studiet viste at det var vigtigt ikke kun at 
have forståelse af populationen, som letter identifikationen af de efterfølgende præ-
diktorer men samtidig også opgørelsen af ressourcer for patientgruppen.  
Overordnet viser afhandlingen, at kendskab til patientpopulationen, identifikation af 
relevante ressourcetræk for samme gruppe, inklusion af individers epidemiologiske 
og adfærdsbestemte karakteristika som prædiktorer til forbruget af sundhedsydelser, 
og valg af statistisk model, alle er vigtige parametre at afklare inden en model af 
forbrug af sundhedsydelser konstrueres. Dette gælder for såvel sundhedsviden-
skabelige som samfundsvidenskabelige forskere.  
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CHAPTER	1. 	
INTRODUCTION	
One of the biggest challenges for both economies and societies nowadays is the 
burden of patients suffering from one or more chronic diseases. Chronic diseases are 
the leading cause of death worldwide, but these are partially preventable through 
interventions aimed at modifiable risk factors such as tobacco and alcohol use, 
unhealthy diets, and physical activity. Thus, the United Nations has proposed a 
political declaration to prevent and control these non-communicable diseases [1]. In 
Denmark, an estimated one out of every three individuals is living with a chronic 
condition, and this has a significant effect on their quality of life. Thus, the potential 
to improve lives is immense, but, ideally, this should be accomplished without 
increasing healthcare budgets.  
The epidemiological transition since 1900 has shifted the leading causes of death 
from microbial investigations and towards chronic diseases and resulted in decreased 
infant mortality and increased life expectancy [2]. In Denmark, the life expectancy at 
60 years of age was 21 years for men and 24 years for women in 2012 (Statistics 
Denmark). The most recent World Health Statistics [3] showed that in high-income 
countries, including Denmark, life expectancy has increased by 4.8 years for men and 
3.7 years for women since 1990. Furthermore, the number of Danish citizens above 
65 years of age is expected to increase by 50% in the next 25 years, from 1 million 
in 2015 to 1.5 million by 2040. This change in population structure will inevitably 
increase the incidence rates of chronic diseases, resulting in a significant burden of 
highly prevalent diseases such as cardiovascular diseases, diabetes, cancers, and 
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osteoporosis. Individuals’ self-care is becoming increasingly important within the 
healthcare system, as patients living with a chronic condition at a mild stage require 
less treatment. These patients are tossed between different sectors of the healthcare 
system, as the division of labour is often not specified in detail. Thus, an increased 
use of case management for chronic patients to support treatment across sectors has 
been observed since the turn of the century. 
The amount of resources allocated to health care has increased substantially in the 
last decades – especially in the United States, where private health insurance 
dominates the market, and the total health expenditures accounts for approximately 
17% of the gross domestic product (GDP). Within Europe, this number is 
substantially lower, but despite this constitutes close to 10% of GDP [3]. The increase 
in morbidity, combined with expensive treatments to target patients with chronic 
diseases will increase the total healthcare costs unless we can determine how to 
allocate resources more beneficially. Therefore, it is necessary to know how much in 
terms of costs these groups of patients accumulate regarding healthcare and if certain 
subgroups – e.g. lower socioeconomic groups – respond better to certain 
interventions, and thus accumulate fewer total health costs.   
The organisation of healthcare systems is fundamentally different around the world, 
but can roughly be divided into three groups – the Beveridge model, the Bismarck 
model, and the market-oriented model [4]. The models are listed in order of 
expenditures per GDP with systems originating from the Beveridge model being the 
least expensive. Common to most systems, however, is the lack of a true market, with 
all the market failures that follow. In Denmark, the Beveridge model has been 
adopted, with taxes almost entirely financing the entire integrated healthcare system, 
with some fees required for dental treatments and pharmaceuticals.  
This dissertation is an attempt to highlight the importance of epidemiological factors 
for health economic research on chronic diseases. Within health economics, the need 
for models that can predict healthcare costs is of substantial importance as decisions 
to introduce as well as decommission healthcare services is based on these. 
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CHAPTER	2. 	
THEORETICAL	FOUNDATION	
2.1. MODELS	OF	HEALTHCARE	COSTS	
Econometric models of healthcare costs are used for many purposes, amongst others 
program and treatment evaluations [5] and analyses concerning the allocation of 
resources [6]. Modelling health costs, however, is not an easy task, as these exhibit 
characteristics that are difficult to replicate. Firstly, a significant proportion of 
individuals consume no healthcare resources, which leads to a substantial number of 
observations at zero. Within health economics, this is often handled using two-part 
or generalised Tobit models [7]. Secondly, when individuals consume health care 
services, a small minority consume a high proportion of the total costs, often due to 
clinical complications or comorbidities. The cost distributions, therefore, become 
skewed, kurtotic and heteroscedastic.  
Traditional linear regression has been shown to perform poorly with respect to health 
costs [8], as ordinary least squares minimise prediction error and, because of the 
extreme values, this may result in the overfitting of data [7]. Some of the initially 
proposed methods for analysing healthcare costs with non-normal distributions 
focused on transforming data into more symmetric distributions. However, this 
results in regression models that cannot predict healthcare spending on the original 
cost scale [7]. Other transformation models, including the Box-Cox and 
semiparametric models, have since been proposed, but retransformation onto the 
original cost scale is still troublesome [7]. Another way to analyse these data is using 
nonlinear regression models, which assume a nonlinear relationship between 
predictors and the cost regression. One method for this is the generalised linear model 
approach, where prediction is performed on the original cost scale, while allowing 
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for heteroscedasticity. The limited number of pre-specified links and distributional 
families can, however, impose bias if these are incorrectly estimated [8]. Basu and 
Rathouz [9] proposed a more flexible version of the generalised linear model, called 
the extended estimating equations, and this has been shown to perform better than 
other models on most parameters [8].  
Several studies have demonstrated that extended estimating equations provide the 
best fit for data within healthcare, but have simultaneously concluded that marginal 
effects were not significantly different than if less computationally difficult models 
were used, such as linear ordinary least square or gamma models with log link [8–
10]. These results are, however, more pronounced in the younger adult population 
and for total costs compared with prescription drug expenditures [8]. Furthermore, 
previous studies have shown that patients with chronic conditions consume 
substantially more healthcare costs compared to matched controls [11,12]. Thus, it 
can be argued that results from other studies modelling healthcare costs from the 
general public cannot be directly transferred to patients with chronic diseases. For 
these reasons, caution is advised when modelling healthcare costs in older chronic 
populations.  
The methods mentioned above only predict the conditional mean, and while this is 
an important feature, other aspects of the distribution might also be of importance 
[13,14]. For example, when a clinician is treating a patient, the decision is seldom 
based on ‘the average benefit’ but rather the potential to maximize the benefits to the 
individual, and even more so if the clinician believes that ‘the average benefit’ will 
cause harm to a particular patient [13]. In these cases, the econometric models of 
interest should predict the probability of high-end parameters or the entire 
distribution instead of predicting the conditional mean [15]. This could guide 
clinicians to recommend lifestyle changes that are not only beneficial from a clinical 
perspective but also from an economic one. 
Healthcare costs are defined as “the total expenditure, both public and private, on 
healthcare services” [16]. These costs can be considered either from a country, group, 
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or individual perspective [16]. Between countries, variations exist with respect to 
what is regarded as a healthcare cost, and thus, discrepancies exist regarding whether 
or not to include items such as nursing home costs and other health-related social 
costs [17]. For the purposes of this dissertation and the appended papers, healthcare-
related costs will be assessed using the costs of all hospital services, the costs of 
general practitioners and specialists, and the costs of prescriptions redeemed from 
any pharmacy. Ideally, over-the-counter medication and costs related to care outside 
the hospital should have been included as well.  
When modelling healthcare costs, the perspective of the given analysis should be 
considered carefully. Most models within the existing literature utilise data from 
restrictive perspectives, such as costs related to pharmacies, hospitals or primary care 
physicians [8,15,18,19]. However, the models often attempt to estimate impact in a 
broader societal perspective [20]. Thus, separate models need to be fitted for different 
resources, or new models must be constructed to handle this.  
Within the literature on models for healthcare costs, no studies have been identified 
discussing which explanatory variables to include to produce the best fitting model 
or whether the variables that are included are relevant with respect to the decision the 
given model should inform. However, from a health policy and clinical point of view, 
these things ought to be considered, as they could potentially affect the decisions that 
are made.  
2.2. THE	BEHAVIORAL	MODEL	AND	SOCIOECONOMIC	STATUS	
One approach to explaining differences in utilization of healthcare costs is to 
investigate behavioural patterns. One theory for this is the behavioural model, which 
was developed in the late 1960s to explain why families use health services [21], and 
has since evolved to explain individuals utilization of health services [22]. The initial 
model suggested that the use of health services was a function of predisposing 
characteristics, enabling resources and needs [21], while later versions included 
factors explaining the health care system, the external environment, and personal 
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health practices [22]. The latest version, illustrated in Figure 1, is more dynamic and 
repeating in the explanation of the use of healthcare services, as this is a repetitive 
process throughout life, but also focuses on both the contextual and individual 
determinants of healthcare utilization [23].  
 
Figure 1 – Illustration of the behavioural model (phase 5) by Andersen [23].  
The contextual characteristics are concerned with community age structure, the 
supply of medical personnel and facilities, and mortality, morbidity and disability 
rates. The individual characteristics encompass age, gender, insurance, income, and 
social structure. Health behaviour includes the use of health services, the patient’s 
health practices and the interaction between providers and patients. Lastly, outcomes 
can be measured as effective and/or efficient access [22,23]. 
In continuation of the behavioural model, the social determinants of health consist of 
societal-level influences and individual-level risk factors [24] and include but is not 
limited to race/ethnicity, religion, socioeconomic status, sexual orientation, and 
disability [24,25]. Focusing on these will provide opportunities to improve the health 
of our society, but critics have argued that understanding and improving health 
require a focus directed at societies rather than individuals, and this may be difficult 
to achieve [24]. Therefore, it is important to change the view from investigating 
services for ill patients towards factors that can improve health [26].  
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One of the social determinants often investigated within epidemiological research is 
socioeconomic status, which can be defined as a “measure of one's combined 
economic and social status and tends to be positively associated with better health” 
[27]. Socioeconomic status is believed to influence health in three ways; in the ability 
to purchase treatment and health-promoting resources, through different 
socialisations of health habits between socioeconomic groups, and by health having 
an influence on socioeconomic status rather than vice versa [27]. Most classifications 
of socioeconomic status are primarily based on or include occupation as a factor by 
which to group individuals, e.g. Goldthorpe’s class scheme [28]. However, these 
measures can be very problematic to apply on populations where the majority are 
elderly, and thus classified as pensioners. Thus, studies have reported on the 
individual variables that can be used to determine socioeconomic status when 
investigating this population [29–31]. In this thesis and the appended papers, 
socioeconomic status will be measured using the surrogate outcomes of highest 
completed education, personal income, marital status, and type of community living, 
as these represent potential confounder or effect modifiers for utilization of 
healthcare costs.  
Within the Nordic countries, surrogate measures of socioeconomic status are 
routinely registered on a national level in registries. With the introduction of the civil 
registration system in 1968 it has been possible to conduct large population studies 
in Denmark [32] and since then the number of registers in Denmark has grown 
substantially. Research within this area continues to grow, and the term big data is 
now used to describe this phenomenon. 
2.3. REGISTER‐BASED	RESEARCH	AND	STATISTICS	
The theoretical framework of register-based research is still in the making, as the first 
paper on this topic was published in 1995 [33,34]. Since then some methodological 
papers in this area have discussed the use and quality of registry data for academic 
research. Compared to other surveys, register surveys are not embedded in a well-
established methodological framework. Wallgren and Wallgren [35] introduced six 
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basic principles regarding preconditions and methodology for conducting good 
quality research on registers. These include the identity number, legal, 
transformation, system, consistency, and quality principles. These can be seen as the 
beginning of the development of a more generally accepted theory, and has led to the 
publication of the second edition of Wallgren and Wallgren’s methodological book 
in 2014 [35], but this methodology is still in its early stage of development. One of 
the areas where a method has been proposed is for errors that occur in register-based 
research [36]. Where sampling errors is often used in sample surveys to assess the 
random errors that are unavoidable in any study [37], it is more appropriate to 
investigate the non-sampling errors within register surveys by identifying coverage 
errors between different registers [38]. Other non-sampling errors include linkage, 
differences between the purpose of collection and usage, control processes, missing 
data, and interest in specific registered data [36].  
As register-based statistics originated from survey theory, much of the language to 
describe register-based research has been transferred from that theoretical 
framework. However, here is a need for a more register-specific terminology to 
separate these approaches and to develop a more comprehensive methodology [39].   
A register is defined as a complete list of the objects in a population (e.g. 
all individuals in Denmark) including data on each object’s identity, 
which makes it possible to update and expand the register with new 
variable values for each object. [40] (p. 9)  
This definition of a register is the one used in this thesis and embraces both 
administrative and statistical registers. Within register-based statistics, the term 
object is used to denote the entities included. This term differs from the sample survey 
terminology, where entities are referred to as subjects because of the active process 
of inclusion and the written/oral declaration of consent. The identity of objects 
included in a given register is determined using a unique identification number that 
never changes in order to avoid a breach of data. A register can only be considered 
as such if the identification number is present because it must be possible to update a 
register and this function disappears with the identification number. In Denmark the 
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unique personal identification number is called CPR-number and is provided to all 
persons who are born or take up permanent residence in Denmark [32].  
The basis for most of the data collection is for administrative purposes, and, therefore, 
discrepancies arise between the needs of the researchers and the purpose of data 
collection, which is a crucial difference between register surveys and sample surveys 
[41]. In the latter case, the researcher is solely responsible for the selection of the 
study population, choice of study variables, and, therefore, the quality of the survey. 
Sample surveys, such as traditional epidemiological studies, furthermore, apply 
statistical inference, which cannot be applied to register surveys due to the massive 
number of observations and different sources of microdata. Thus, Wallgren and 
Wallgren introduced the system approach to accommodate these statistical challenges 
[39].  
Making quality improvements and editing registers for register surveys is more 
complicated than for sample surveys, as both base registers and all linked registers 
need to be assessed, and thus, changes in these affect more than just the current 
register survey [39]. The strengths and weaknesses of register surveys have been 
extensively described elsewhere [39,41,42]. Some of these arguments can introduce 
both strengths and weaknesses, e.g. when data is collected independently of the 
research question. Recall bias and subject influence on the diagnostic process is 
reduced but can result in unavailable or inaccurate data for the purpose of the study. 
Often data collection within registers is complete and thus entire population studies 
for both rare diseases and exposures are possible at a fraction of the cost compared 
to if traditional epidemiological studies were to investigate the same issue. However, 
another implication is when researchers identify missing data. This type of missing 
data can be difficult to explain, lead to the incorrect interpretation of results, and can 
lead to under-coverage [41]. 
Missing values within registers are different from those in sample surveys and must 
be handled accordingly. That is, only objects with a contact to the hospital will be 
recorded in National Patient Register (NPR) and thus, if combined with other 
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registers, any variables originating from the NPR will produce missing values if this 
object has never been in contact with a hospital. One method to handle this in a 
sample survey is to impute missing values[43], but this would produce wrong values 
for register surveys, and thus, the imputed values should be zero in such cases.  
The use of administrative registers on their own may limit the producible results, but, 
as described in Wallgren and Wallgren [39], the integrated register system where 
different registries are linked through the use of personal identification numbers 
enables more comprehensive analyses that benefit from the qualities that each 
registry provides. 
2.3.1. THE	INTEGRATED	REGISTER	SYSTEM	
Administrative data may originate from different sources and hence different 
registers. Combining these creates a system of coordinated statistical registers – i.e. 
the integrated register system [44]. The advantage of working in one system is good 
coverage and consistency, given that the six basic principles are followed [44]. The 
integrated register system used for this thesis comprised data from the National 
Patient Register (NPR), Civil Registration System, National Prescription Registry, 
Register of Cancer, The National Health Insurance Service Registry, Register on 
Causes of Death, and Population’s Education Register. Table 1 includes more details 
about the different registers. 
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Name of register Translated name Content 
Year of 
registration 
Centrale person register Civil Registration 
System 
Information on residence and 
relationships of all citizens  
1974 - present 
Dødsårsagsregisteret Cause of Death 
Register 
Information on causes of death 
based on death certificates 
1970 - present 
Lægemiddelstatistik-
registeret 
National 
Prescription 
Registry 
Information on dispensed 
prescription drugs 
1994 – present 
Landspatientregisteret National Patient 
Register 
Information on diagnoses and 
operations performed at hospital 
1976 - present 
Skatteregisteret Tax registry Information on taxable incomes 1980 - present 
Sygesikringsregisteret The National Health 
Insurance Service 
Register 
Information on providers, health 
services and citizens receiving 
primary health care treatment 
1990 - present 
Uddannselsesregisteret Population’s 
Education Register 
Information on citizens approved 
educations 
1973 - present 
Table 1 –Details about the registers included in the integrated register system. Additional 
information is available from Statistics Denmark and The Danish Health Data Authority.  
 
Throughout this dissertation, the variables with the highest quality of information 
were chosen for analysis. Statistics Denmark introduced high-quality variables to 
their registers in 2006, with detailed information and documentation for all high-
quality variables. For these variables, descriptions of the period of application, 
contingent data breaches, data quality assessment, and topic clusters exist. Today, 
more than 700 variables are included in this quality assurance initiative, including 
diagnosis of action at the hospital (NPR) and highest completed education 
(Population’s Education Register). Within the ten topic clusters, this dissertation 
primarily relied on the social relations and health, education, personal finance, and 
population variables.  
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2.4. THE	RESEARCH	QUESTION	
This dissertation will attempt to highlight the importance of epidemiological factors 
for health economic studies on chronic diseases. As presented in the theoretical 
framework, previous research on models to predict healthcare costs are only 
concerned with a limited amount of epidemiological knowledge. Policy makers and 
clinicians are, however, often more interested in which predictors influence specific 
outcomes. In the ensuing parts of this dissertation, the chronic disease osteoporosis 
will be the case considered, as this is a highly prevalent disease, which results in 
increased morbidity and mortality for those affected. Furthermore, this results in 
different utilisations of healthcare services because of its complexity.  
The appended papers should not be considered as the outcome of the research 
question, but merely supporting arguments. The research question addressed in this 
thesis is: 
 
How do individual epidemiological factors  
impact the healthcare utilisation of patients  
with a chronic disease, e.g. osteoporosis? 
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CHAPTER	3. 	
OSTEOPOROSIS	–	A	CHRONIC	
DISEASE	
Osteoporosis is one of the biggest public health concerns, that has increased 
concurrently with the increasing length of life of the population. Osteoporosis in itself 
is not easily detected, and thus many patients remain undiagnosed. In 2010, the 
estimated prevalence of osteoporosis was 27.6 million individuals in a population of 
400 million, solely in the European Union [45]. Fragility fractures are the main 
consequences resulting from osteoporosis, with an estimated 3.5 million incident 
fractures occurring in the European Union in 2010 [45], and these fractures have been 
shown to increase both morbidity [46] and mortality [47]. In Denmark a fracture of 
the femoral neck is the 14th most common diagnosis for patients admitted to hospital 
and accounts for 2% of all admissions. Furthermore, a fracture of lower end of the 
radius is the 7th most common reason for an outpatient visit and 5th for emergency 
room contacts [48]. Thus, this disease constitutes a substantial part of healthcare 
costs, with an estimated economic burden of the illness and the resulting fractures in 
the European Union of €37 billion in 2010, and this is expected to increase by 23% 
in 2025 entirely due to changes in the population demographic [45]. 
Osteoporosis was defined as “a disease characterized by low bone mass and 
microarchitectural deterioration of bone tissue, leading to enhanced bone fragility 
and a consequent increase in fracture risk” in 1991 by 14 leading experts [49]. Many 
countries worldwide have adopted another criterion for diagnostic purposes, which 
defines osteoporosis as “a bone mineral density (BMD) that lies 2.5 standard 
deviations (SD) or more below the average value for young healthy women” [50] – a 
measure that is referred to as a T-score. However, the clinical definition necessitates 
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a Dual-energy X-ray Absorptiometry (DXA) scanner to diagnose osteoporosis, and 
these are primarily located in specialist clinics.  
Bone fragility is a multifactorial disease, where both genetics and environmental 
factors influence an individual's risk of fracture. Age and gender are the two most 
important risk factors for osteoporosis and thus fragility fractures. The gender 
difference is evident in that the disease predominately affects women, with 
approximately 40% of postmenopausal women and 15% of men above 50 years of 
age expected to fulfil the diagnostic criterion [51]. Oestrogen deficiency after 
menopause results in more bone resorption than bone formation, and together with 
lower peak BMD could explain why women after the age of 50 sustain two-thirds of 
all incident fractures [52].  
Even though the incidence rate of hip fractures has continuously decreased since 
2001 [53], the number of hip fractures is not going decline as rapidly, and is even 
expected to increase in Europe in the future, given the changing population 
demographic [54].  
3.1. OSTEOPOROTIC	FRACTURES	
The variation in fracture incidence rates across the world has been well investigated 
[55], with European countries, and, in particular, Scandinavian countries, having the 
highest hip fracture rates in the world. A 10-fold difference in the age-standardised 
rate of hip fractures can be observed across the world and exceeds the within country 
difference between genders [55]. This difference between countries could be 
explained by the correlation between hip fracture probability and both latitude and 
gross domestic product (GDP) [56]. The proposed reasons for these findings were 
less sun exposure and thus lower levels of Vitamin D, and decreased physical activity 
with increasing socioeconomic status.  
There has been some dispute about which fractures should be included in the 
definition of osteoporotic fractures, but the most recognized method is to include all 
fractures arising from low trauma injuries, such as tripping over the doorstep. 
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Therefore, almost all hip, vertebral, and wrist fractures occurring after the age of 50 
will be considered low-energy fractures and thus osteoporotic [57]. The risk of 
sustaining a fracture as a woman is almost double that for men; however, this varies 
within different fracture sites[58]. Other fractures, such as ankle, face, finger, toe, 
and foot, are still not consistently included when discussing osteoporotic fractures 
[59], because these kinds of fractures occur more seldom than hip, vertebral and wrist 
fractures and have therefore not been shown to be more prevalent in osteoporotic 
patients compared to the general population [60].  
Future studies on osteoporotic fractures should investigate other fracture groups; such 
as the humerus, tibia, and proximal radius/ulna, and not merely group these as “other 
fractures”. Despite the lack of focus on these, studies have shown that these are also 
signs of osteoporosis based on BMD [60]. Many of these fractures are observed less 
frequently than hip, vertebral, and wrist fractures [58], which is why a possible 
approach could be to utilise national patient registers where fractures are registered. 
For example, a humerus fracture is considered an osteoporotic fracture; it is very 
frequently observed [45] but not grouped separately as hip or forearm fractures are 
(e.g. [61]). Also, the long-term consequences of fractures should be investigated more 
thoroughly, as most studies are terminated before there have been five years of 
follow-ups, and thus, the effect of future fractures in the following decade remains 
unclear.  
This thesis distinguishes between two kinds of subsequent fracture types: recurrent 
fractures – i.e. where index and subsequent fractures were of the same type – and 
second fractures – i.e. where index and subsequent fractures were of different types. 
This is based on the assumption that the bone in which the original fracture occurred 
must be porous and, thus, be more likely to break again compared to other bones in 
the individual’s body. However, the NPR does not register whether a fracture occurs 
in the right or left extremity. Therefore, data on recurrent fractures might be second 
fractures if e.g. the index fracture occurred in the left humerus and the recurrent 
fracture occurred in the right humerus.  
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3.2. CLINICAL	MODIFIABLE	RISK	FACTORS	
FOR	OSTEOPOROTIC	FRACTURES	
Non-pharmaceutical interventions for the prevention of osteoporosis focus on 
modifiable risk factors, as illustrated in Figure 2. Vitamin D and calcium deficiency 
are some of the most significant nutritional risk factors to consider for osteoporosis 
and fragility fracture prevention, as they influence the bone mineralization. 
Supplementing these is more efficient if these are supplied together compared to 
separately [62]. Poor nutrition can furthermore lead to low body mass index, which 
is another well-established risk factor [63], which also increases the risk of fracture, 
most likely due to the diminished body weight at fragile sites of the body. Another 
risk factor to consider is physical activity, which prevents bone loss and increases 
BMD, thus improving balance and coordination, and furthermore reduces the risk of 
falling and thereby fracturing a bone [64]. Smoking influences the risk of fracture 
and has an independent, dose-dependent effect on bone loss, which increases the risk 
of hip fracture by up to 40% [65]. This effect is, however, reversible, as no significant 
difference in BMD has been shown between former and non-smokers, but a 
significantly lower BMD has been shown in current smokers compared with non-
smokers [65]. Additionally, alcohol is a risk factor that influences both BMD and risk 
of fracture because it affects both the skeletal fragility and increases the risk of falling 
as a result of intoxication [66,67]. Lastly, use of glucocorticoids has been shown to 
increase the possibility of fracture both for intermittent and prolonged use [68]. 
Educating patients in osteoporosis using multifaceted group education can impact the 
patients’ engagement in the management of their disease [69]; however, it has limited 
or no effect on the behaviour of patients in regards to clinical risk factors [70]. 
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Figure 2 – Simplified illustration of fracture risk due to modifiable risk factors, adapted from 
Abrahamsen et al. [70] and reproduced with permission of Nature Publishing Group. 
Despite the potential effect of these modifiable risk factors on the risk of future 
fractures, not all patients will benefit from lifestyle changes because non-modifiable 
risk factors such as gender and age together with race/ethnicity and genetic 
predisposition are as or more important risk factors for osteoporotic fractures. Thus, 
pharmaceutical interventions are still needed to prevent future fragility fractures. 
3.3. TREATMENT	AND	MANAGEMENT		
In Denmark, the Danish Endocrine Society has composed the national guidelines for 
treatment of osteoporosis. They recommend performing biochemical tests and a DXA 
scan for all patients presenting with a low-energy fracture in order to diagnose 
osteoporosis. Patients already receiving anti-osteoporotic medication are routinely 
scanned every 2–3 years to investigate whether the medication has an effect [71].  
General practitioners are only allowed to prescribe anti-osteoporotic medication for 
patients if at least one of four pre-defined criteria is fulfilled. These include, among 
others [72]: 
Modifiable	risk	factors	
Impaired	
physical	activity	
Drug	exposure	
Glucocorticoids	
Alcohol	
Moderate	to	high	intake	
Poor	nutrition	Smoking	
Low	vitamin	D	Low	weight	
BMI <21 kg/m2
Increased	risk	of	fracture	
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 Persons with x-ray verified low-energy fracture of the hip and/or spine. A 
spine fracture is defined as: 
o Reduction in height of >20% of the anterior vertebral compared to 
posterior height 
o Reduction in height of >20% at any site, compared to the above or 
below vertebrae 
 Persons with at least one risk factor for the development of osteoporosis, 
and with a BMD measurement in the hip and/or spine with T-score < -2.5 
SD.  
 Persons with T-score <-4.0 SD without simultaneous risk factors. 
 Persons in current or scheduled systemic glucocorticoid treatment 
(equivalent to >5 mg of prednisolone per day for three months or more; or 
intermittent use with a total use for more than three months within one year) 
with a BMD-measurement in the hip and/or spine where the T-score is <-
1.0 SD.  
The risk factors comprise, but are not limited to, genetic predisposition, body mass 
index < 19 kg/m2, previous fractures, osteogenesis imperfecta, menopause before 45 
years of age, systemic treatment with glucocorticoids, smoking, excess alcohol 
consumption, and patients at increased risk of falling.  
In Denmark, the bisphosphonate alendronate is the first choice of pharmaceutical 
therapy for all patients, unless the general practitioner can argue otherwise. Thus, 
alendronate is used to treat nine out of ten Danish osteoporotic patients [73]. Several 
systematic reviews and meta-analyses have been published on the clinical effects, 
and side-effects, of anti-osteoporotic medications, and, in particular, bisphosphonates 
[61,74–94]. These show that all bisphosphonates significantly reduce the risk of 
vertebral fractures and zoledronate and alendronate minimize the possibility of hip 
fractures. However, treatment with a bisphosphonate is not without risks, as severe 
atrial fibrillation, stroke [78,88] and atypical femur fractures [74,77,85] are 
occasionally reported with use of bisphosphonates.  
Most publications reporting the effects of anti-osteoporotic medications originate 
from those randomised controlled trials mentioned above, where the population and 
compliance can be investigated in more detail. The effectiveness in the entire 
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population using anti-osteoporotic medications, which in 2014 constituted 
approximately 100,000 Danish citizens [95], has not been reported to the same extent. 
Particularly, given the low persistence and diversity observed in this patient group 
[96,97]; future studies on improving the outcome for osteoporotic patients should 
consider this. 
3.4. HEALTHCARE	COSTS	AND	OSTEOPOROSIS	
Most health economic analyses on osteoporosis or osteoporotic fractures are 
economic evaluations based on cohort models, where mean costs are used to predict 
the cost-effectiveness of two or more alternatives. The most comprehensive of these 
publications was conducted by the National Institute for Health and Care Excellence 
(NICE), which investigated the secondary prevention of fragility fractures in 
postmenopausal women. The results showed that pharmaceutical treatments were 
cost-effective for women aged 65 or older with confirmed osteoporosis, for women 
aged 60–64 with confirmed osteoporosis and with one clinical risk factor, and for 
women aged 55–59 with confirmed osteoporosis and two or more clinical risk factors 
[98]. The treatment was only cost-effective as a first-line use for alendronate and not 
for other bisphosphonates [98]. 
Patients with multiple chronic conditions, such as many osteoporotic patients, show 
many varying patterns for healthcare cost distributions because their healthcare 
utilisation is influenced by many different factors and not necessarily concerned with 
one specific condition [99]. Thus, merely analysing the mean cost of a population 
might reveal incorrect results, because the effects observed are not caused by the 
disease, but may be the results of unobserved variables. Furthermore, it can be 
difficult to differentiate healthcare utilisation in countries where payments are 
aggregated, such as using diagnosis-related group (DRG) tariffs. Patients may be 
admitted with a broken bone, and this might be caused by osteoporosis, but if the 
patient simultaneously had diabetes and suffered from hypoglycemia at the time of 
the fracture, then the actual cause of the fracture might not be recorded, and thus 
future research using these data would produce erroneous results. 
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Studies have shown that the average utilization of healthcare-related resources differs 
substantially between different groups of fracture patients, which underscores the 
need for differentiating on this when performing economic evaluations [54,100,101]. 
Borgström et al. [100] showed that patients with hip fractures accumulated 
significantly more costs for inpatient care compared to vertebral and wrist fractures, 
whereas wrist fracture patients accumulated more for the costs of outpatient care. 
Additionally, costs associated with community care were significantly higher for 
vertebral fracture patients compared to patients with hip fractures, and almost non-
existent for wrist fracture patients. Hiligsmann et al. [101] demonstrated that the level 
of compliance with anti-osteoporotic medications was significantly associated with 
the total cost, as the cost of medicines increased with increasing medication 
possession ratio, and this consequently lowered the cost of the disease. Lastly, age 
and gender also significantly influences the average total cost for osteoporotic hip 
fracture patients [54] and thus differentiating between groups of patients is necessary 
from a health economic perspective. Decision makers should, however, be aware that 
these results might not be directly transferable to their setting, as the average cost of 
treatment may vary depending on which treatment regime is offered and the 
organisation of the healthcare system. 
The effect of modifiable risk factors, such as obesity, smoking, and excess alcohol 
consumption, on the utilisation of healthcare mimic that on health, i.e. obesity has the 
most effect on the outcome [102]. Data on these are, however, not routinely recorded 
in registers, and thus controlling for these in the major population-based studies is 
difficult.  
3.5. SOCIOECONOMIC	STATUS	AND	OSTEOPOROSIS	
When looking at socioeconomic variables and their association with the utilisation of 
healthcare in general, studies have shown that higher education increases the number 
of visits to a general practitioner, and most significantly for women. 
Widowed/divorced women have a tendency to increase their number of visits, 
whereas single men have significantly fewer visits. Furthermore, higher income 
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decreases the number of visits to a general practitioner. This picture slightly changes 
when looking at the utilisation of specialists, where higher education and income 
significantly increases the number of visits. Furthermore, living in a rural community 
also increases the number of visits to a specialist [103]. These associations are, 
however, influenced by the contextual characteristics of the healthcare system, 
particularly the type and organisation. Thus, associations observed in American 
studies are probably not generalizable to a Danish setting.  
Few studies have investigated the association between different socioeconomic 
variables and utilisation of healthcare for osteoporotic patients [104,105]. Both 
studies have focused either on a limited part of the services utilised for osteoporosis 
and furthermore only investigated one surrogate measure of socioeconomic status – 
income. More research is needed to determine if the socioeconomic status is 
associated with the amount of utilisation of healthcare services for osteoporotic 
patients, but more interestingly how big these associations are, and if these can be 
used for improving treatment regimes. The combination of epidemiological and 
health economic research traditions could improve the knowledge on which policy 
makers make decisions on where to allocate resources.  
A few studies have been published on the associations between epidemiological 
outcomes and socioeconomic status, and these results might likewise be replicable 
for health economic outcomes, as an increased incidence of epidemiological 
outcomes would increase the utilisation of healthcare services. A review of the 
literature on socioeconomic status and osteoporotic fractures found eleven studies of 
sound quality that investigated the association between these [106]. In particular, the 
studies looked at income, education, occupation, type of residence, and marital status. 
The studies found no significant evidence for any association between increased 
fracture risk and education or income, while marriage was correlated with a decreased 
risk of fracture. The generalizability of these studies is, however, limited by the 
varying methods used for measuring the different variables of socioeconomic status 
and fractures. Furthermore, the generalizability of these associations across different 
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population is also troublesome, as the effect of low socioeconomic status would affect 
health differently. No previous studies have investigated the combined effect of 
socioeconomic status on the rate of death following a fracture. Some studies have 
shown that some variables, such as marital status [107] and residence [108], affect 
mortality, but without controlling for other socioeconomic variables, it is hard to 
determine if this effect is truly caused by e.g. marriage or if the observed effect is 
merely a moderate of other causes. Future research should investigate if the same 
tendencies for clinical outcomes can be observed with respect to outcomes of health 
utilisation. 
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CHAPTER	4. 	
CONTRIBUTIONS	FROM	THIS	
THESIS	
When performing research, it is important to understand both the setting in which it 
is conducted, and the methods applied. The researchers who investigate the models 
of healthcare costs extensively and in-depth are primarily trained as economists or 
biostatisticians and only later acquire some knowledge about healthcare research. 
This becomes very apparent when dissecting the models proposed for predicting the 
costs of healthcare, as these very often contain very limited if any information about 
the included predictors for these models. The reason for this is most likely the 
theoretical appreciation common to social sciences, which is different from the 
methodology applied to health sciences. This produces research that is innovative and 
advanced regarding methodology but which lacks application potential, as these 
results tends to be written off by clinicians. On the other hand, when researchers 
within the health sciences produce research on healthcare utilisation they tend to 
focus more on choosing the accurate predictors and making sense of the possible 
interactions between these, in order to yield results that can be generalised and inform 
future decisions. This produces research that is often used as the basis for decisions, 
as clinicians trust the results from their peers but lack the understanding of how costs 
behave in economic models and lack understanding of how predictors depend on 
characteristics of the national/regional health care system. This may lead to erroneous 
conclusions and the introduction of health services under false pretences. Thus, there 
is a need for more joint venture research between these two sciences, as this could 
potentially combine the best of both worlds.  
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4.1. THE	POPULATION	
Osteoporosis is the chronic disease investigated throughout this thesis. To make any 
predictions about the amount of healthcare utilisation, the population investigated 
must be characterised. As described in the previous chapter, patients suffering from 
osteoporosis are not easily detected, and thus, the clinical manifestations of 
osteoporotic fractures are often investigated instead.  
In the first paper included in this thesis [53], the osteoporotic fracture population was 
investigated from an epidemiological perspective in order to understand the 10-year 
effect of a fracture on the risk of future fractures and death. The results showed that 
fractures in other areas, such as the humerus, lower leg, and femur, were as likely to 
be associated with subsequent fractures as typical osteoporotic fractures. 
Furthermore, the results showed that appendicular fractures were more often linked 
to proximal fractures of the same limb, compared to other fractures. This can be seen 
in Table 2. The conclusion was that recurrent fractures constituted the most 
significant associations between the index and subsequent fractures and that fractures 
of the distal parts of the extremities often resulted in subsequent proximal fractures 
of the same extremity.   
Surveys investigating incidence rates for fractures in such detail as this study are very 
rare because it is very time-consuming to do so and it is often impossible to recruit 
the population needed for traditional epidemiological studies. Thus, register surveys 
can facilitate more knowledge being gained concerning untraditional fracture types, 
for which little is known.  
Furthermore, the results from the first paper [53] suggest that e.g. when modelling 
the cost of healthcare utilisation, it is important to consider the history of the 
individual, as this could affect the outcome later on as patients with previous fractures 
are likely to experience more expensive fractures in the following decade.  
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Table 2 - Gender-stratified 10-year subsequent fracture incidence in per cent, for both 
men and women 
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4.2. DIFFERENT	SECTORS	–	DIFFERENT	COSTS	
After identifying the population of interest, the researcher investigating the utilisation 
of healthcare, should determine which parts of the healthcare sector are being utilised 
by this patient group and whether these are important to consider in the analysis. As 
described previously (Chapter 2 - Models of healthcare costs) most studies on models 
of healthcare costs focus on very narrow cost perspectives, such as only 
hospitalisation or pharmaceutical costs.  
In the second paper included in this thesis [109], the cost of osteoporosis and 
osteoporotic fractures were investigated. This was estimated at €1.6 billion in 2011 
[109], of which the municipalities carried the biggest burden for ensuring 
rehabilitative care after the patients had been discharged from the hospital. Figure 3 
is an illustration of the share each payer identified in the model carries and shows 
that the municipalities pay more than half of the total costs.  
This study was among the first to illustrate the enormous resource burden for 
osteoporotic patients that lie outside the healthcare system. The proportion of costs 
Figure 3 - Total accumulated costs with the simplified osteoporotic Markov model stratified 
into payers. Results are presented as a percentage of the total costs [109].  
21,34 24,75
0,67
0,74
57,06 55,31
6,69 6,3
13,97 12,9
0%
20%
40%
60%
80%
100%
Men Women
Productivity Cost
Patient
Municipality
General practice
Region
 
27 
 
associated with community care has previously been estimated substantially lower 
[100]. In other countries, where municipalities are not responsible for rehabilitative 
care as in Denmark, this burden would most likely fall on the patients. Additionally, 
this study adopted a very broad societal perspective, and thus the burden for Denmark 
appears much larger than for other countries that are very similar. The yearly costs 
related to osteoporosis in the European Union have previously been estimated at €37 
billion, where incident fractures represent 66% of these costs [45]. If, instead, the 
expenses of the individual states are compared, with respect to e.g. the cost of hip 
fractures, then the result of the present study is lower compared to other previously 
published estimates [100,110]. Thus, future studies investigating health economic 
aspects of osteoporosis or osteoporotic fractures should consider adopting a broader 
societal perspective, as substantial costs are located outside the healthcare system. 
Future studies trying to predict the cost of healthcare utilisation for a chronic disease 
should carefully consider which perspective to adopt, based on what decision the 
authors are interested in informing. With the accumulation of costs from different 
sectors, it is possible that the cost distributions will result in even more skewedness, 
heteroscedasticity, and fewer individuals with zero costs.  
4.3. CHOOSING	APPROPRIATE	CLINICAL	PREDICTORS	
Following the choice of population and costs, the researcher should consider which 
variables could potentially explain the variations in healthcare costs. Here the 
researcher should consider whether he or she believes that all individuals within the 
population are truly from the same population, and thus have covariates that behave 
similarly across the range of the outcome. To explain the behaviour of healthcare cost 
accumulation, the clinical predictors are of particular relevance. As emphasised in 
the presentation of the case of osteoporosis, variables such as anti-osteoporotic 
medications, modifiable risk factors, and previous fractures all influence the clinical 
outcome of the disease and therefore potentially the healthcare utilisation.  
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Through the work on the third paper included in the thesis, which investigated the 
clinical risk factors that predicted which osteoporotic patients, who despite 
compliance to medication, continued experiencing fractures, the literature was 
searched for which clinical risk factors might affect the outcome for this patient 
group. Unfortunately, many of the a priori variables, mostly related to modifiable 
risk factors are not routinely registered in the Danish registers, the data source of four 
of the five studies included in this dissertation. This includes information about 
alcohol and tobacco use, body weight, nutrition, and physical activity – i.e. all but the 
use of medication from Figure 2. 
Several comorbidities that have previously been linked to osteoporosis were 
identified. These included anorexia nervosa, asthma, celiac disease, chronic 
obstructive pulmonary disease, dementia, hyperparathyroidism, inflammatory bowel 
disease, lactose intolerance, lupus, renal disease, rheumatoid arthritis, and stroke. 
There is a potential influence from these with regards to exacerbating osteoporosis, 
and hence a possible increase in healthcare utilisation. 
4.4. CHOOSING	APPROPRIATE	BEHAVIORAL	PREDICTORS	
The first and third paper only utilised the clinical subset of the integrated register 
system [53]. Thus, a substantial, and previously unutilised, part of this system might 
provide other variables that could explain the difference in utilisation of healthcare.  
Of the different behavioural variables that could potentially influence healthcare 
utilisation, as presented in Andersen’s behavioural model (Figure 1), demographic 
and social characteristics were of particular interest in the fourth paper. This fourth 
study investigated the influence of socioeconomic status on two epidemiological 
outcomes, as several papers have suggested this might have an influence, but without 
coming to any definitive conclusions. The predictor variables investigated were 
education, income, marital status, and type of community residence. Furthermore, 
this paper differentiated between fracture groups, whereas the previous literature had 
investigated osteoporotic fractures in general or only the major osteoporotic fractures. 
 
29 
 
The predictor variables chosen were easily identifiable within the Danish registers 
for all objects, with the exception of education for a very specific subgroup. The 
mechanisms for these ‘missing’ values were investigated, and this was primarily 
present for women born before 1960. The probable reason for this is the Population 
Education Register was introduced in the 1970s – shortly after the civil registration 
number. Attempts have been made to update the information for objects with 
completed education before the introduction, but a substantial amount of missing 
values is still observed [111]. Instead of performing a complete case analysis, a new 
category called “missing values” was added to all four socioeconomic variables to 
control for any missing observations. 
The results showed a clear relationship between both outcomes and socioeconomic 
status. Decreased rate of death was significantly associated with living with a spouse 
and higher income quintiles for all thirteen fracture groups. Furthermore, there was a 
tendency towards decreased rate of death being associated with higher education, but 
only significantly for the forearm, distal forearm, hand and foot fractures. Lastly, the 
results did not indicate any association between rural/urban living and rate of death. 
A decreased rate of subsequent fracture was often associated with living with a 
spouse and remote residence, however, not to the same extend as for rate of death. In 
conclusion, low socioeconomic status was associated with both increased risk of 
subsequent fracture and post-fracture mortality. Therefore, these variables might 
potentially also influence the utilisation of healthcare. 
4.5. 	THE	IMPACT	OF	CLINICAL	AND	BEHAVIORAL	
PREDICTORS	ON	UTILISATION	OF	HEALTHCARE	SERVICES	
The fifth paper aimed to demonstrate the importance of including clinical and 
behavioural predictors for the utilisation of healthcare services across all thirteen 
groups of fractures.   
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4.5.1. METHODOLOGY	
The previously investigated predictor variables were combined with healthcare-
related costs from general practices, hospitals, and pharmacies, and this resulted in 
the fifth paper. Even though the second paper showed that social care cost – i.e. 
services provided by the Danish municipalities – would account for the largest 
healthcare utilisation for osteoporotic fracture patients, object-specific costs were not 
available from the integrated register system utilised, and, hence, this utilisation 
could not be included in this study.  
The thirteen fracture groups previously identified (paper IV) constitute the population 
used for this article. The socioeconomic status variables (paper IV) and the clinical 
risk factors (paper III and paper IV) were included if relevant and correlated with 
healthcare-related costs. Comorbidities affecting mortality were incorporated using 
the updated Charlson Comorbidity Index Score [112]. 
The study was designed as a three-part model, however without an attempt to 
combine the three components. A logistic regression model was fitted for the zero 
cost objects in the study, and generalised linear models (GLM) for the remaining two 
components. The model’s assumptions for logistic regression model were tested 
using locally weighted scatterplot smoothing, standardized Pearson residuals, and the 
Hosmer-Lemeshow goodness of fit test[113]. The model’s assumptions were 
assessed with a link test, Park test and modified Hosmer-Lemeshow test[114]. Robust 
variance estimates were used to avoid overdispersion.  
In this dissertation, hip fractures will be used to demonstrate the model, but results 
for all thirteen fracture groups are presented in the manuscript for the fifth paper. The 
crucial difference between the thirteen groups was the amount of accumulated costs 
and hence different cut-off points between the second and third components.  
Hip fractures  
The density of the observed 1-year accumulated healthcare-related costs is illustrated 
in Figure 4. The first component included zero cost objects, the second component 
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included objects with accumulated healthcare-related costs amounting to no more 
than €7000, and the third and final component included objects with accumulated 
healthcare-related costs amounting to €7000 or higher. The cut-off point at €7000 
was chosen as this separates the two distinct distributions seen in Figure 4.  
 
 
Figure 4 – Cost distribution of 1-year accumulated healthcare-related cost (€) for hip fracture 
objects 2008-9 (zero-costs excluded). 
A logistic regression model was chosen for the first component, a GLM with identity 
link and a gamma distribution for the second component, and a GLM with square 
root link and inverse Gaussian distribution for the third component. The goodness of 
fit and Wald tests were used to verify the model assumptions for the logistic 
regression, and these were not violated. Both GLMs passed the linktest, but in regards 
to the choice of variance function the deviance residuals and Park test were not in 
agreement for the second component. In the end, the gamma distribution was chosen, 
because the residuals were normally distributed using normality plots.  
4.5.2. RESULTS	
Across all thirteen fracture groups, more than one-third of objects had previously 
collected a prescription of glucocorticoids, more than one-third had previously 
experienced a fracture, and null-cost objects had a significantly higher mortality in 
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the year after fracture. A diagnosis of excessive alcohol consumption was found in 
10–15% of objects and 5–10% had a diagnosis or pharmacy prescription relating to 
smoking. Generalising results from the regression analyses, costs accumulated in the 
year before fracture had no influence on which objects accumulated costs or not in 
the year after a fracture. Age, gender and glucocorticoid use was significantly 
associated with utilisation of healthcare services for all three components across all 
fracture groups. Socioeconomic status variables only had a sporadic significant effect 
on healthcare-related costs. Any presence of comorbidities, measured by the 
Charlson Comorbidity Index Score, was the variable that had the largest influence on 
whether objects (regardless of fracture group) accumulated healthcare-related costs. 
Female gender and living with a partner appeared as the most salient characteristics 
holding down the accumulation of costs. When objects (regardless of fracture group) 
accumulated costs, high income was the variable that reduced the accumulation of 
healthcare-related costs the most. Use of medication for alcohol addiction or smoking 
cessation, on the other hand, were the factors most likely to result in excessive 
accumulation of healthcare-related costs. These results can be found in the fifth paper 
that is included in this dissertation. 
Results for hip fracture patients showed that null-cost objects were significantly 
older, more often male, had higher Charlson index scores, were previously treated 
with anti-osteoporotic medication, live alone, and live in urban communities, see 
Table 3. As described above, the presence of comorbidities was the variable that 
increased the probability of accumulating costs the most and female gender and living 
with a partner also here decreased the likelihood of accumulating costs (component 
1). When objects did accumulate healthcare-related cost, they would either end up in 
the second or third component. The GLM model for the second component showed 
that increasing healthcare-related costs was significantly associated with lower age, 
a higher Charlson Index Score, current/previous anti-osteoporotic medication use, 
smoking-related diagnosis, glucocorticoid use, and urban living (Table 3). For this 
component, income decreased the accumulation of costs the most, whereas anti-
osteoporotic medication and use of glucocorticoids increased accumulation the most. 
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For the third component, i.e. objects with higher healthcare-related cost, increasing 
healthcare-related cost was significantly associated with higher ages, higher Charlson 
index scores, smoking-related diagnosis, alcohol diagnosis, glucocorticoid use, lower 
income, and urban living (Table 3). Again, income decreased the accumulation of 
costs the most, but here living in an intermediate municipality had the largest 
marginal effect on the accumulation of healthcare costs. 
Despite the very significant results observed for both clinical and socioeconomic 
predictors in the previous paper, this was not as evident in this analysis, which 
sparked curiosity whether this was a result of the accumulation across different types 
of costs. 
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Table 3 – Results from regression models for estimation of the influence of clinical and 
socioeconomic status variables on total accumulated costs one year after a hip fracture. 
Hip fracture 
 
 
Component 1 
(Odds Ratio) 
Component 2 
(average 
marginal effects) 
Component 3 
(average marginal 
effects) 
Age *1.047 * -4.69 *30.90 
Gender, female *0.426 -37.71 -131.92 
Charlson index score 
 1-2 
 3+ 
 
*1.744 
*3.166 
 
*202.00 
43.00 
 
*805.08 
*1859.54 
Anti-osteoporotic 
medication 
 Current 
 Ever 
 
 
1.063 
*1.742 
 
 
*243.64 
*277.17 
 
 
362.03 
8.51 
Smoking-related diagnosis 0.824 *219.14 *1826.26 
Alcohol diagnosis 1.030 -34.67 *1510.77 
Glucocorticoids 0.875 *329.91 *1365.81 
Previous fracture 0.814 50.61 297.88 
Education 
 Secondary 
 Higher 
 
0.929 
0.869 
 
22.97 
52.70 
 
122.33 
459.98 
Income 
 2nd Quintile 
 3rd Quintile 
 4th Quintile 
 5th Quintile 
 
0.819 
0.721 
0.815 
0.698 
 
-114.66 
-82.25 
13.07 
-92.06 
 
* -833.39 
-550.20 
-465.78 
* -1155.68 
Marital status, with partner *0.713 49.87 -200.73 
Rural/urban living 
 Rural 
 Intermediate 
 Urban 
 
1.523 
*1.705 
*1.988 
 
101.79 
39.51 
*149.33 
 
477.33 
*1937.64 
*1490.97 
Cost one year before fracture 1.000 *0.01 *0.09 
* p<0.05 
Charlson index score: no comorbidities are baseline. Anti-osteoporotic medication: never 
treated is baseline. Education: basic education is baseline Income: 1st Quintile is baseline. 
Rural/urban living: rural is baseline. 
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4.5.3. SUBANALYSIS	OF	DIFFERENT	COSTS	
A sub-analysis of all three cost components – i.e. costs from secondary care, costs 
from the redemption of prescription medication, and costs from primary care – was 
carried out in order to identify if this significantly influenced the conclusion 
regarding the effect of socioeconomic and clinical predictor variables on healthcare-
related expenditures. For the costs of secondary care, a square root link and inverse 
Gaussian family GLM were fitted, for the costs of prescription medication an identity 
link with poisson family GLM was fitted, and for the costs of primary care, a log link 
with gamma family GLM was fitted. 
Null-cost objects (component one) 
The subdivision into cost categories significantly influenced the results both for null-
cost objects and those who did accumulate costs following a hip fracture (see Table 
4, Table 5, and Table 6). For null-cost objects, clinical predictors significantly 
increased the risk of not accumulating secondary care costs, with the exact opposite 
tendency observed for medication and primary care costs. For both medication and 
primary care, null-cost objects were significantly more likely to live alone, whereas 
this had no effect on the cost of secondary care. Also, null-cost objects in regards to 
medication and primary care were significantly more often urban community 
residents, but this variable had no effect on null-cost objects for the cost of secondary 
care. Higher income quintiles reduced the likelihood of belonging to the null-cost 
object group with respect to both medication and primary care but increased the 
likelihood with respect to secondary care. Education was not significant for any group 
of costs in regards to null-cost objects. The driving predictors for the accumulation 
of healthcare-related costs were a smoking-related diagnosis and higher income with 
respect to secondary care, whereas living in an intermediate municipality was the 
predictor that drove objects towards not accumulating costs. Equivalent to primary 
care and medication costs, the presence of comorbidities drove the model for objects 
to accumulate costs the most, whereas female gender was the driving force in 
decreasing the accumulation of costs. 
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Objects’ accumulated costs (component two) 
With respect to objects’ accumulated costs, higher education and living with a partner 
increased the costs of primary care significantly, but neither had any effect on the 
costs of medication or secondary care. Both urban communities and lower income 
increased the accumulation of costs for secondary care, but neither of these 
influenced the costs of medication or primary care. Clinical predictors significantly 
increased the accumulation of costs with respect to both secondary care and 
medication but had less effect on primary care costs. The driving predictor for 
primary care and medication costs to increase was the use of smoking cessation drugs, 
whereas alcohol diagnosis and presence of comorbidities were the driving force in 
decreasing the accumulation of primary care costs, and higher education was likewise 
for medication costs. For the cost of secondary care, the presence of comorbidities 
and living in an intermediate or urban municipality were the main predictors. In this 
subgroup, higher income was the driving force in decreasing the accumulation of 
secondary care costs.  
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Table 4 – Results from regression models for estimation of the effect of clinical and 
socioeconomic status variables on accumulated costs from secondary care one year after a 
hip fracture 
Cost of secondary care, € Component 1  
(Odds Ratio) 
Component 2 
(average marginal effects) 
Age 1.006  [1.002; 1.011] 44.02   [17.80; 70.24] 
Gender, female 0.967  [0.895; 1.046] -251.01  [-728.31; 226.30] 
Charlson index score 
 1-2 
 3+ 
 
0.925  
1.106  
 
[0.849; 1.008] 
 [0.948; 1.289] 
 
547.40  
1642.91  
 
[26.51; 1068.3] 
[433.22; 2852.60] 
Anti-osteoporotic medication 
 Current 
 Ever 
 
1.125  
1.099  
 
[1.009; 1.255] 
[0.928; 1.300] 
 
198.27 
-64.49 
 
[-457.00; 853.55] 
[-1044.18; 915.21] 
Smoking-related diagnosis 1.211  [1.057; 1.389] 1714.92 [784.87; 2644.96] 
Alcohol diagnosis 0.906  [0.805; 1.020] 1600.83 [803.83; 2397.83] 
Glucocorticoids 0.953  [0.887; 1.025] 981.97 [548.97; 1414.97] 
Previous fracture 0.954  [0.887; 1.025] 77.53 [-352.18; 507.25] 
Education 
 Secondary 
 Higher 
 
1.069  
1.061  
 
[0.987; 1.158] 
[0.934; 1.206] 
 
157.67 
415.87 
 
[-306.56; 621.90] 
[-361.19; 1192.93] 
Income 
 2nd Quintile 
 3rd Quintile 
 4th Quintile 
 5th Quintile 
 
1.033  
1.134  
1.144  
1.131  
 
[0.914; 1.168] 
[1.000; 1.285] 
[1.011; 1.295] 
[0.998; 1.281] 
 
-560.75 
-290.87 
-519.42 
-984.50 
 
[-1266.69; 145.19] 
[-1051.10; 469.37] 
[-1261.09; 222.24] 
[-1688.20; -280.80] 
Marital status, with partner 1.009  [0.923; 1.103] -44.59 [-572.63; 483.45] 
Rural/urban living 
 Rural 
 Intermediate 
 Urban 
 
0.959  
0.876  
0.977  
 
[0.852; 1.080] 
[0.767; 1.000] 
[0.870; 1.096] 
 
361.14 
1623.35 
1121.73 
 
[-254.61; 976.88] 
[867.28; 2379.42] 
[500.49; 1742.97] 
Cost one year before fracture 0.999  [0.999; 1.000] 0.08 [0.06; 0.11] 
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Table 5 - Results from regression models for estimating the effect of clinical and 
socioeconomic status variables on accumulated costs from redemption of prescription 
medication one year after a hip fracture 
Cost of medicines, € Component 1  
(Odds Ratio) 
Component 2 
(average marginal effects) 
Age 1.020 [1.012; 1.030] 1.56 [0.47; 2.64] 
Gender, female 0.460 [0.395; 0.535] 11.93 [-10.56; 34.42] 
Charlson index score 
 1-2 
 3+ 
 
1.864 
3.164 
 
[1.588; 2.187] 
[2.483; 3.986] 
 
76.84 
93.16 
 
[47.01; 106.67] 
[23.11; 163.21] 
Anti-osteoporotic medication 
 Current 
 Ever 
 
0.980 
1.329 
 
[0.769; 1.249] 
[0.953; 1.854] 
 
-1.20 
47.76 
 
[-37.17; 34.77] 
[-6.89; 102.41] 
Smoking-related diagnosis 0.707 [0.518; 0.965] 117.76 [71.23; 164.29] 
Alcohol diagnosis 0.968 [0.759; 1.234] 41.47 [8.11; 74.83] 
Glucocorticoids 0.772 [0.663; 0.899] 72.40 [49.83; 94.97] 
Previous fracture 0.842 [0.723; 0.980] 6.49 [-13.98; 26.97] 
Education 
 Secondary 
 Higher 
 
0.994 
0.882 
 
[0.848; 1.166] 
[0.675; 1.152] 
 
16.21 
-20.14 
 
[-7.88; 40.31] 
[-52.73; 12.44] 
Income 
 2nd Quintile 
 3rd Quintile 
 4th Quintile 
 5th Quintile 
 
1.014 
0.620 
0.778 
0.833 
 
[0.799; 1.287] 
[0.478; 0.806] 
[0.606; 1.000] 
[0.652; 1.066] 
 
10.68 
15.09 
31.17 
-5.21 
 
[-25.01; 46.37] 
[-20.94; 51.13] 
[-12.59; 74.93] 
[-39.17; 28.74] 
Marital status, with partner 0.810 [0.676; 0.970] 0.44 [-28.11; 28.99] 
Rural/urban living 
 Rural 
 Intermediate 
 Urban 
 
1.258 
1.627 
1.751 
 
[0.953; 1.661] 
[1.211; 2.185] 
[1.344; 2.282] 
 
12.66 
-7.35 
25.32 
 
[-17.45; 42.77] 
[-41.29; 26.58] 
[-5.09; 55.75] 
Cost one year before fracture 0.999 [0.999; 1.000] 0.68 [0.66; 0.71] 
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Table 6 - Results from regression models for estimation of the effect of clinical and 
socioeconomic status variables on accumulated costs from primary care one year after a hip 
fracture 
Cost of primary care, € Component 1  
(Odds Ratio) 
Component 2 
(average marginal effects) 
Age 1.042 [1.035; 1.049] 2.09 [0.72; 3.46] 
Gender, female 0.525 [0.471; 0.587] -2.62 [-30.81; 25.57] 
Charlson index score 
 1-2 
 3+ 
 
2.204 
4.956 
 
[1.969; 2.468] 
[4.166; 5.895] 
 
-19.83 
-22.28 
 
[-49.44; 9.80] 
[-77.68; 33.10] 
Anti-osteoporotic medication 
 Current 
 Ever 
 
0.925 
1.216 
 
[0.783; 1.093] 
[0.959; 1.541] 
 
42.48 
56.29 
 
[10.95; 74.00] 
[-6.03; 118.61] 
Smoking-related diagnosis 1.003 [0.820; 1.226] 90.65 [40.20; 141.10] 
Alcohol diagnosis 0.986 [0.822; 1.182] -29.12 [-68.48; 10.25] 
Glucocorticoids 0.898 [0.807; 0.998] 79.20 [55.90; 102.50] 
Previous fracture 0.888 [0.799; 0.988] -12.42 [-36.29; 11.44] 
Education 
 Secondary 
 Higher 
 
0.960 
0.855 
 
[0.855; 1.078] 
[0.700; 1.046] 
 
34.08 
80.22 
 
[7.70; 60.45] 
[37.17; 123.26] 
Income 
 2nd Quintile 
 3rd Quintile 
 4th Quintile 
 5th Quintile 
 
1.053 
0.679 
0.743 
0.725 
 
[0.886; 1.251] 
[0.565; 0.816] 
[0.618; 0.892] 
[0.603; 0.872] 
 
6.17 
4.63 
33.61 
29.04 
 
[-35.25; 47.60] 
[-35.71; 44.97] 
[-6.84; 74.06] 
[-10.83; 68.91] 
Marital status, with partner 0.880 [0.769; 1.007] 66.85 [37.14; 96.56] 
Rural/urban living 
 Rural 
 Intermediate 
 Urban 
 
1.148 
1.250 
1.267 
 
[0.960; 1.373] 
[1.026; 1.521] 
[1.066; 1.506] 
 
17.35 
-5.96 
23.00 
 
[-18.64; 53.33] 
[-46.77; 34.85] 
[-11.66; 57.66] 
Cost one year before fracture 0.999 [0.999; 0.999] 0.54 [0.49; 0.59] 
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4.6. RECOMMENDATIONS	FOR	PREDICTING	
THE	EFFECT	OF	EPIDEMIOLOGICAL	
FACTORS	ON	HEALTHCARE	COSTS		
Through the dissertation and the appended papers, four preliminary steps are 
recommended before building a regression model that can predict the effect of 
epidemiological factors on healthcare expenditures. These are based on knowledge 
from both the social and health sciences, which emphasizes the importance of 
interdisciplinary research. 
Firstly, the researcher should become familiar with the population of interest, as this 
will ease the subsequent steps. This should at least include a review of the 
epidemiological literature and ideally an epidemiological study of the particular 
population of interest. Furthermore, these identifications will facilitate hypothesis 
generation for which predictors could potentially influence the utilisation of 
healthcare costs, as knowledge about the population will guide the a priori selection 
of variables for further investigation. 
Secondly, economists and clinicians should jointly determine the appropriate 
resource use and hence which costs to include in the study. When investigating 
chronic diseases where different parts of the health sector are utilised, this steps 
becomes crucial, as the omission of one or more sectors could influence the results. 
Additionally, the choice of the time horizon for the analysis should be carefully 
considered and based on knowledge about the population. Despite its importance, 
this part was not investigated during this thesis, as costs were limited to four years of 
observations.  
Thirdly, all important predictors should be jointly determined by both economists and 
clinicians. For clinical predictors, this identification is most easily facilitated by 
investigating the risk factors for clinical events related to the chronic disease of 
interest, e.g. future fractures for osteoporosis. These factors will often be potential 
confounders for both the clinical outcomes and healthcare expenditures. 
Additionally, behavioural predictors of importance should be identified as these 
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could potentially confound the utilisation of health services. One method to identify 
these by is using a theoretical model, such as the behavioural model applied in this 
study. The proposed mechanisms for health behaviour will moderate the utilisation 
and are therefore important to consider when predicting healthcare costs.  
Fourthly, consideration of the most appropriate statistical model is important for the 
results of the analysis, as the initial theoretical review found that the choice of the 
econometric model could potentially affect the result of the analysis. As shown in the 
fifth paper, behavioural and clinical predictors had a different effect on the outcome 
depending on which sector the expenditures originated in. This emphasises the 
importance of the second and fourth steps of the model, as erroneous conclusions 
may be drawn if narrow perspectives are chosen.  
The associations between the different aspects of the prediction model and 
application of results from the different papers appended to this dissertation are 
graphically presented in Figure 5.  
 
42 
 
 
Figure 5 – Summary of results. A schematic representation of the association between 
socioeconomic status and clinical risk factors for future fractures and accumulation of 
healthcare-related costs as outcomes within an osteoporotic population.  
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CHAPTER	5. IMPLICATIONS	AND	
FUTURE	RESEARCH	
When life expectancy increases by as much as what has been observed in the last 
century, the incidence of different diseases shifts. An increase in diseases such as 
diabetes, chronic heart disease, and osteoporosis has been observed during the same 
period and may be a result of this. Research within the health sciences has discovered 
many new drugs that have also contributed to the increase in life expectancy. Whereas 
people died from diabetes up until the 1920s, today they can live an almost symptom-
free life due to the discovery of insulin. Despite the obvious advantages of an aging 
population, the concomitant diseases that follow with older age significantly worsen 
the health outcomes. This dissertation has attempted to emphasise the need for 
knowledge from the traditional health sciences to inform economic models for 
healthcare utilisation. The combination of theoretical frameworks across these 
different fields of research could produce research that borrows the best of both 
worlds. The proposed four-step model comprises one possible strategy for this. As 
illustrated through the papers appended to this dissertation, the choice of population, 
perspective, predictors, and statistical model is important when estimating the 
conditional mean healthcare costs for fracture patients. The results of this dissertation 
may be based on osteoporotic fractures, but nothing suggests that these steps would 
be any different for other chronic diseases. Applying this to another population, e.g. 
diabetics, could be interesting in order to verify this. 
Defining the population of interest is the crucial first step to emerge from this 
dissertation. One of the key results of this thesis was the identification of the wider 
fracture population. Future analyses were the cost of osteoporotic fractures are 
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included should consider the difference in cost accumulation across different groups 
of fractures and would be well advised not to group these together as “other 
fractures.” As illustrated in both the dissertation and the appended papers, a vast 
diversity exists between the different fracture groups and a number of different 
outcomes. The morbidity and mortality following a fracture are significantly different 
between groups, and this affects the influence of different predictors’ effect on these 
outcomes. This is most likely due to differences in the individuals’ demographic 
characteristics, and, as a result, grouping very diverse fracture groups such as ankle 
and humerus fractures into one will most likely result in insignificant associations. 
Exploring the true effects is difficult in a smaller population where fractures are 
observed in fewer numbers, and hence, population studies utilising data from national 
registers could elucidate the true effect.   
Previous studies, e.g. Seeley et al. [115], have shown a fracture of the humerus, 
especially of the proximal location, to be osteoporotic and associated with low bone 
mass. Despite the acknowledgement of this, most recent clinical studies with 
osteoporotic fractures as endpoints concentrate on hip, vertebral, and non-vertebral 
fractures [61]. The specification of the additional fracture groups will add to the 
knowledge about health behaviour for fracture patients and allow for potential 
differentiations to be made between individuals who experience a fracture. Another 
important finding from the first paper was the increased rates of subsequent a fracture 
at proximal sites compared to the index fracture. In particular, lower leg fractures 
resulting in subsequent hip fractures and wrist fractures resulting in humerus fractures 
were as high in fracture rates as some second fracture rates. Cuddihy et al. [116] 
found the 10-year subsequent fracture rate to be 55% following a forearm fracture 
and that the risk of humerus fractures, in particular, increased, which supports the 
argument from the first paper, that distal fractures can predict future proximal 
fractures in the same extremity. This knowledge is important also from an economic 
perspective, as health expenditure accumulation is influenced by an individual’s 
history with the healthcare system and risk factors for future events. This association 
between the accumulation of costs and knowledge about previous fractures was 
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confirmed in the fifth paper with respect to both medication and primary care costs, 
where a previous fracture was found to increase the likelihood of accumulating costs 
(component one). Further, it could be speculated that this association would be even 
more pronounced for social costs, as previous fractures would likely lead to a higher 
rate of absence from work and decreased productivity, and, hence, further 
productivity loss. Additionally, it is possible that previous fractures could result in 
increased need for assistive devices and lead to greater use of nursing homes and/or 
respite care.   
The second step was to identify the appropriate perspective and thus the relevant 
resources for the analysis. Within the literature on health economics, the textbooks 
stress the importance of there being sufficiently broad perspectives for informing 
decisions [20], whereas the applied research focuses on narrow perspectives 
[8,15,18,19]. This can affect the result of the analysis of healthcare utilisation if e.g. 
social care was omitted from analyses of an osteoporotic population, as the second 
paper in the thesis showed that this could constitute more than half of all costs. 
Furthermore, if results from such narrow perspective analyses are used as the basis 
for decisions, this may lead to erroneous conclusions being drawn, as these could 
shift the recommendation in decision analytical models. Furthermore, this step also 
emphasises choosing the appropriate time horizon for the analyses. In the fifth paper 
this was, however, limited to a one-year perspective due to a lack of data, but ideally 
future research should investigate this over a longer time period, as this could 
potentially also affect the results.  
Choosing the accurate predictors for healthcare utilisation is another crucial element. 
From a clinical framework, it is well documented that different risk factors and the 
patient’s history is decisive for the clinical outcome and thus healthcare utilisation. 
This is also evident from the behavioural model, where health outcomes are 
determined by personal health practices, the process of medical care, and the use of 
personal health services, which is also influenced by the contextual characteristics 
and individual characteristics. The epidemiological studies conducted in relation to 
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this thesis, and similar publications from experts within the field of osteoporosis, 
have documented the importance of identifying clinical predictors both when 
investigating clinical outcomes as well as costs, as these have a significant effect on 
the outcome of interest. But clinical risk factors are not the only factors that influence 
the outcome for osteoporotic patients. Previous studies have shown that 
socioeconomic variables, such as income, have a significant influence on the rate of 
future fractures and mortality [29,30,108,117–121]. However, these have primarily 
focused on hip, vertebral, and wrist fractures, whereas the fourth paper in this thesis 
shows that these associations are seen across a wide range of fracture groups. This 
emphasises the need to consider predisposing individual characteristics of health 
behaviour. When looking at behavioural factors, which have been investigated using 
socioeconomic status, in particular, as predictors, the same certainty in the effect on 
a given outcome has not been demonstrated as with clinical predictors. Only a few 
studies have been identified that investigate the effect socioeconomic predictors have 
on both epidemiological outcomes as well as costs. Furthermore, the behavioural 
factors are more difficult to measure and hence incorporate into prediction models.  
Some of the included elements in the behavioural model, though important to 
generally consider, are less important to investigate when considering the case of 
osteoporosis in a Danish setting. However, if these results were to be generalised, 
factors pertaining to both the individual’s and the healthcare service’s - such as health 
policy, financing, and the organisation - could potentially be quite different and thus 
affect the use of healthcare services.  
Furthermore, the application of the behavioural model is only one method to control 
for societal and behavioural factors that might influence the results of the analyses. 
Other, both more and less complicated, models exist and could potentially have been 
utilised instead. The memory or feedback mechanism essential to the behavioural 
model was only incorporated through the variables of previous fracture, chronic 
conditions, and to some extent previous years’ utilisations of healthcare services. This 
is not sufficient, as the model includes a lot of other feedback that contributes to the 
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current health status, and future models for prediction of healthcare utilisation should 
consider other ways or other types of models that could integrate some memory, such 
as discrete event simulations within decision analytic models.   
The results from the fifth paper highlight the necessity of understanding the process 
of medical care and the organisation of the healthcare system. Only investigating the 
healthcare expenditures from an accumulated costs perspective would hide the true 
effects of the different predictors on the utilisation of healthcare services. The effects 
observed for accumulated costs changed significantly for the sub-analysis on 
individual cost categories. Leal et al. [104] has previously investigated the predictors 
of one-year hospitalisation costs following a hip fracture and found that gender, age, 
income, and Charlson Comorbidity index score were significantly associated with 
this outcome. The fifth paper attempted to demonstrate this relationship in all thirteen 
fracture groups using a larger set of socioeconomic variables. However, no 
generalizable association between health care utilisation and socioeconomic status 
was observed. Future research on this area could focus on understanding the 
association between different socioeconomic variables in relation to epidemiological 
outcomes and higher costs. And specifically which of these predictors have the 
largest effect on the outcome, as this might be of interest to policy makers.   
However, future research is advised for understanding the effect of behavioural 
predictors, and especially socioeconomic status, on the utilisation of healthcare costs. 
Results from both this thesis and previous studies indicate that the true connection 
between these has yet to be identified. This could include studies where different and 
other surrogate variables for socioeconomic status are investigated. Perhaps 
individual income is not as good a predictor as the accumulated income of the family, 
or education might be an inferior predictor compared to the designation of 
occupation. This leads to the consideration of structural conditions, as the behavioural 
model suggests that contextual characteristics influence individual ones. Hence, 
socioeconomic status could be investigated from a contextual perspective as well – 
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i.e. income might be less influential on the outcome if the healthcare system is 
organised in a particular way.   
Lastly, the proposed model emphasises that taking steps to ensure that the most 
appropriate statistical model is used is important for the results of the analysis. When 
investigating the predictors for healthcare utilisation and incorporating elements from 
both health and social sciences, it is important to acknowledge the previous research 
from these fields. Not only must social scientists familiarise themselves with 
epidemiological results that could be of importance to the study they are about to 
conduct, but researchers within the health sciences should also consider the theories 
of how healthcare costs behave and how these are best modelled. Hence, the fourth 
step of the proposed model from this dissertation emerges. Researchers within the 
social sciences have acknowledged that traditional and easy computational statistical 
models for continuous outcomes, such as ordinary least squares regression analysis, 
are not adequate when studying healthcare costs. Instead, they propose more complex 
models that can handle most of the difficulties that arise with healthcare costs. This 
acknowledgement should be recognised by health scientist when using such models. 
This observation is supported by the results from the fifth paper, where the 
accumulation of all healthcare-related costs generated unusual distributions, which 
lead to the three-part regression model. Furthermore, the sub-analysis revealed that 
the included predictors behaved very differently and often in opposite ways between 
different types of healthcare costs. Hence, an ordinary least squares analysis of these 
accumulated costs would have led to an erroneous conclusion about the effect of 
predictors on the utilisation of healthcare costs. 
Four of the five appended papers to this dissertation are based on data from registers 
and hence are grounded in register-based statistics. The quality and generalizability 
of different registers have often been discussed, primarily because the populations 
which these are based on are limited to certain groups within society. In healthcare 
systems based on the Bismarck model, it can be almost impossible to collect data for 
the entire population, as sickness funds and insurance companies are often 
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contributors of data to these registries. However, problems may also arise for systems 
based on the Beveridge model. In the United Kingdom the Clinical Practice Research 
Datalink is only able to collect data from volunteering general practices, and though 
the study population is representative of the entire population, only 6.9% of all 
residents are included in this database [122]. However, within the Scandinavian 
countries and especially Denmark, registers enable research using the entire 
population as the sample. These studies are not limited by which subjects are willing 
and able to participate. Furthermore, register-based research facilitates the 
investigation of effectiveness rather than efficacy, which would be the result of 
clinical trials. These results could then inform decision models on treatment of e.g. 
osteoporotic fractures, but using other effect measures than health-related quality of 
life. One of the challenges with register-based research in Denmark is the restrictions 
placed by Statistics Denmark, in terms of the re-identification of objects and data use. 
Despite this, a few studies have been able to investigate the coverage and quality of 
data from different Danish registers [123,124].  
All five papers included in this thesis have used the arbitrary exclusion criterion for 
objects younger than 50 years of age. This was based on the assumption that bone 
mass is primarily constructed during the first two decades of life, after which it 
deteriorates and should not become fragile enough to break until after the age of 50 
from a low-energy trauma [125]. However, it could be argued whether this criterion 
should be lowered. A study, based on the same integrated register system utilised for 
this thesis, showed that the incidence of major osteoporotic fractures increased from 
the age of 40 [126].  
A limitation of the fifth paper is that results cannot be used to generate the average 
cost of different fractures, as results were divided into three separate models for no 
costs, low costs, and high costs. The combination of these models could facilitate 
more specific modelling approaches for results from economic evaluations. This 
could be an issue for further research. Additionally, the data utilised for this last paper 
is not ideal for hospital costs, as these are based on diagnosis-related tariffs, which 
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are generalised tariffs applied for similar diagnoses at different hospitals. This eases 
the budget strain and makes easier the account management from an organisational 
perspective, but will dilute the results with respect to true healthcare expenditures. 
The choice of statistical model for the fifth paper was not challenged by other 
statistical models, despite the knowledge that extended estimating equations might 
produce superior results compared to the generalised linear models used in the paper. 
However, the scope of the paper was not to identify the model of best fit, and, as the 
previous literature has shown no significant difference in the marginal effects 
between the models, this limitation was not investigated further.  
A cautious interpretation of the results from the fifth study is advised, as these are to 
some extent affected by survivorship bias. The detailed results showed that objects 
that accumulated zero costs in the year after a fracture were significantly more likely 
to die during the follow-up period. The average healthcare expenditure per patient 
would consequently be estimated too high if only objects with accumulated costs 
were considered, as has routinely been shown in other studies. 
In conclusion, this dissertation has focused on the impact of different epidemiological 
predictors on the utilisation of healthcare cost for the population of patients who have 
suffered an osteoporotic fracture. The results from this highlight the importance being 
familiar with the population of interest, identifying relevant resources, including both 
epidemiological and behavioural predictors when analysing outcomes from both an 
epidemiological and health economic perspective, and choosing the right statistical 
model to analyse all this with. Both health and social scientists interested in 
researching the utilisation of healthcare should consider these four steps. 
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Healthcare systems around the world continue to see their expenditures in-
crease, measured as a percentage of gross domestic product. Within health 
economics, the need for models that can predict healthcare costs is of sub-
stantial importance, as decisions to introduce as well as to decommission 
healthcare services are based on these. This dissertation is an attempt to 
highlight the importance of epidemiological factors for health econom-
ic research on chronic diseases. Hence, the research question of interest 
is: how do individual epidemiological and behavioural factors impact the 
healthcare utilisation of patients with a chronic disease, e.g. osteoporosis? 
This dissertation proposes a framework for predicting healthcare utilisa-
tion which includes four steps: familiarisation with the study population, 
determining the appropriate resource use, determining which predictors are 
important to consider, and lastly choosing the most appropriate statistical 
model. This framework was developed as a result of five quantitative stud-
ies, of which four were based on patient specific data from registers, and 
one on cost of illness theory. The framework was applied for predicting 
the cost for all fractures patients in one year following the fracture, i.e. the 
fifth study included in this dissertation. This study showed that it is not only 
important to understand the population of interest, as this eases the sub-
sequent identification of potential predictors, but also the healthcare sys-
tem through which these patients are treated, as different resources were 
affected differently by the clinical and behavioural predictors included. 
In conclusion, the results from this dissertation highlight the importance 
being familiar with the population of interest, identifying the relevant re-
sources, including both epidemiological and behavioural predictors, when 
analysing outcomes from both an epidemiological and health economic per-
spective, and choosing the right statistical model to analyse all this with. Both 
health and social scientists interested in researching utilisation of healthcare 
should consider these four steps.
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